Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,289 public trials 1,200 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)

NCT01059188

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Saint Claraspital AG Basel, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
View all 15 locations
View Trial Details
Completed

Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

NCT00600015

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
  • Wellstar Cancer Research Marietta, Georgia, United States
  • Kansas City Cancer Centers Overland Park, Kansas, United States
View all 16 locations
View Trial Details
Completed

Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer

NCT02810457

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site 7814 - Compassionate Care Research Group Fountain Valley, California, United States
  • Research Site 7811 - Innovative Clinical Research Institute Whittier, California, United States
  • Research Site 7803 - 21st Century Oncology Jacksonville, Florida, United States
  • Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd. Joliet, Illinois, United States
View all 147 locations
View Trial Details
Completed

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

NCT02526017

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +47 more
Locations
  • Scottsdale Healthcare Hospitals DBA Honor Health Scottsdale, Arizona, United States
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • Norris Comprehensive Cancer Center, University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center Los Angeles, California, United States
View all 39 locations
View Trial Details
Completed

A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors

NCT02442414

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details
Completed

Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer

NCT03794544

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Fort Myers, Florida, United States
  • Research Site Leesburg, Florida, United States
  • Research Site Baltimore, Maryland, United States
View all 18 locations
View Trial Details

Related conditions